Daniel Demonte

706 total citations
7 papers, 492 citations indexed

About

Daniel Demonte is a scholar working on Cell Biology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Daniel Demonte has authored 7 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cell Biology, 3 papers in Organic Chemistry and 3 papers in Molecular Biology. Recurrent topics in Daniel Demonte's work include Biotin and Related Studies (4 papers), Click Chemistry and Applications (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Daniel Demonte is often cited by papers focused on Biotin and Related Studies (4 papers), Click Chemistry and Applications (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Daniel Demonte collaborates with scholars based in United States. Daniel Demonte's co-authors include Sheldon Park, Christopher M. Dundas, Andrew M. Gulick, Eric J. Drake, Kok Hong Lim, André A. de Thomaz, Okunola Jeyifous, Paul R. Selvin, En Cai and Jary Y. Delgado and has published in prestigious journals such as Applied Microbiology and Biotechnology, Annals of the Rheumatic Diseases and Proteins Structure Function and Bioinformatics.

In The Last Decade

Daniel Demonte

7 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Demonte United States 6 295 129 103 99 93 7 492
Maniraj Bhagawati Germany 13 294 1.0× 45 0.3× 131 1.3× 48 0.5× 113 1.2× 17 455
Yuki Ohmuro‐Matsuyama Japan 13 464 1.6× 128 1.0× 177 1.7× 57 0.6× 125 1.3× 38 661
Brian Filanoski United States 7 392 1.3× 65 0.5× 192 1.9× 86 0.9× 67 0.7× 12 644
Brian Belardi United States 14 354 1.2× 130 1.0× 98 1.0× 158 1.6× 55 0.6× 21 620
Annett Reichel Germany 11 473 1.6× 61 0.5× 179 1.7× 117 1.2× 173 1.9× 12 705
Desiree A. Thayer United States 11 668 2.3× 110 0.9× 75 0.7× 233 2.4× 62 0.7× 13 868
Adrian Fegan United States 11 403 1.4× 51 0.4× 121 1.2× 130 1.3× 74 0.8× 12 623
Bingyun Sun Canada 13 393 1.3× 40 0.3× 92 0.9× 55 0.6× 38 0.4× 35 565
Hiroshi Inaba Japan 16 439 1.5× 176 1.4× 145 1.4× 87 0.9× 38 0.4× 56 776
Alessandro Bosco Italy 13 284 1.0× 34 0.3× 114 1.1× 58 0.6× 58 0.6× 20 551

Countries citing papers authored by Daniel Demonte

Since Specialization
Citations

This map shows the geographic impact of Daniel Demonte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Demonte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Demonte more than expected).

Fields of papers citing papers by Daniel Demonte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Demonte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Demonte. The network helps show where Daniel Demonte may publish in the future.

Co-authorship network of co-authors of Daniel Demonte

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Demonte. A scholar is included among the top collaborators of Daniel Demonte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Demonte. Daniel Demonte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Dillon, Stacey R., Lawrence S. Evans, Katherine E. Lewis, et al.. (2021). OP0039 ALPN-303, AN ENHANCED, POTENT DUAL BAFF/APRIL ANTAGONIST ENGINEERED BY DIRECTED EVOLUTION FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AND OTHER B CELL-RELATED AUTOIMMUNE DISEASES. Annals of the Rheumatic Diseases. 80. 21–21. 3 indexed citations
2.
Lee, Sang Hak, En Cai, Pinghua Ge, et al.. (2017). Super-resolution imaging of synaptic and Extra-synaptic AMPA receptors with different-sized fluorescent probes. eLife. 6. 60 indexed citations
3.
Demonte, Daniel, et al.. (2016). Cell labeling and proximity dependent biotinylation with engineered monomeric streptavidin. 4(3). 152–158. 5 indexed citations
4.
Demonte, Daniel, Naiyi Li, & Sheldon Park. (2015). Postsynthetic Domain Assembly with NpuDnaE and SspDnaB Split Inteins. Applied Biochemistry and Biotechnology. 177(5). 1137–1151. 7 indexed citations
5.
Demonte, Daniel, Christopher M. Dundas, & Sheldon Park. (2014). Expression and purification of soluble monomeric streptavidin in Escherichia coli. Applied Microbiology and Biotechnology. 98(14). 6285–6295. 31 indexed citations
6.
Dundas, Christopher M., Daniel Demonte, & Sheldon Park. (2013). Streptavidin–biotin technology: improvements and innovations in chemical and biological applications. Applied Microbiology and Biotechnology. 97(21). 9343–9353. 351 indexed citations
7.
Demonte, Daniel, Eric J. Drake, Kok Hong Lim, Andrew M. Gulick, & Sheldon Park. (2013). Structure‐based engineering of streptavidin monomer with a reduced biotin dissociation rate. Proteins Structure Function and Bioinformatics. 81(9). 1621–1633. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026